GlassScriptPhysician profile
Asif A Najmuddin
NPI 1376736611
$10,110.12
in general payments reported to CMS, 2019-2025
25 companies · $839 in 2025
The $839 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $11.51 · 2021: $18.89 · 2022: $1,709 · 2023: $781 · 2024: $6,437 · 2025: $839.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,556 · Food and Beverage: $1,970 · Travel and Lodging: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,555.72 |
| Food and Beverage | $1,969.62 |
| Travel and Lodging | $530.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,110.77 | 2024 | |
| Glaxosmithkline, LLC. | $1,002.70 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $859.12 | 2021-2025 | Breztri, Tezspire, Fasenra |
| Ethicon INC. | $791.27 | 2022 | |
| Genzyme Corporation | $198.95 | 2019-2025 | |
| Amgen INC. | $178.42 | 2022-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $158.41 | 2019-2024 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $124.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.13 | 2019-2025 | Ofev |
| Sunovion Pharmaceuticals INC. | $69.29 | 2019 | |
| Genentech USA, INC. | $64.92 | 2019 | |
| Insmed, INC. | $53.30 | 2025 | Brinsupri, Arikayce |
| Baxter Healthcare | $51.88 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Electromed, INC. | $51.60 | 2024-2025 | Smartvest |
| Inogen, INC. | $48.59 | 2022-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $47.78 | 2022-2024 | Watchpatone |
| Grifols USA, LLC | $45.94 | 2019-2023 | Prolastin-C Liquid |
| Philips North America LLC | $35.99 | 2025 | Vest Therapy Und |
| Tactile Systems Technology INC | $34.65 | 2023 | Entre Plus, Flexitouch Plus |
| Circassia INC. | $20.86 | 2019 | |
| Viatris Specialty LLC | $15.40 | 2025 | Yupelri |
| Shire North American Group INC | $15.25 | 2019 | |
| Pinnacle Biologics, INC | $12.52 | 2022 | |
| Mylan Specialty L.P. | $11.87 | 2019 | |
| Sanofi Pasteur INC. | $11.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asif Najmuddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.